Paclitaxel promotes liver graft survival in rats and inhibits hepatocellular carcinoma growth in vitro and is a potentially useful drug for transplant patients with liver cancer

Author: Iesalnieks I.   Tange S.   Scherer M.N.   Graeb C.   Frank E.   Jauch K.W.   Geissler E.K.  

Publisher: Elsevier

ISSN: 0041-1345

Source: Transplantation Proceedings, Vol.34, Iss.6, 2002-09, pp. : 2316-2317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content